FDA Reviews New Data on Anemia Drugs:
Risks for cancer patients
Medical News Today
Expert Summary
FDA reviewed new data on anemia drugs, which included heightened risk of death and tumor growth in cancer patients who're taking these drugs for chemotherapy-induced anemia.
Irina Ostrovsky-Day
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(1 review)
01/18/2008
If you receive anemia drugs (ESA's) and have cancer this article is a must read for you.
Add your rating:
click to select